Hallucinogen Persisting Perception Disorder (HPPD) Research Initiated By Ehave
July 29, 2021 08:30 ET
|
Ehave
HPPD is a psychiatric disorder characterized by the persisting presence of sensory disturbances, most commonly visual, that resemble those produced by the use of hallucinogenic substances. Ehave...
Prescription Digital Therapeutics (PDTx) Market Size Hitting New Highs Explored with CAGR of 11.20%, Opportunities, Revenue, Industry Trends and Forecast by 2027
July 14, 2021 10:54 ET
|
Data Bridge Market Research
SAN FRANCISCO, July 14, 2021 (GLOBE NEWSWIRE) -- Data Bridge Market Research has recently added concise research on the Global Prescription Digital Therapeutics (PDTx) Market report to depict...
Ehave, Inc. To Be One Of Four Main Sponsors At The Third Annual Psytech Summit on July 19th and 20th, 2021
July 02, 2021 08:30 ET
|
Ehave
MIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it will be...
Digital Therapeutics Market Size to Hit $13.80 Billion by 2027, Says Allied Market Research
April 07, 2021 10:55 ET
|
Allied Market Research
Portland, OR, April 07, 2021 (GLOBE NEWSWIRE) -- As per the report, the global Digital Therapeutics Market was pegged at $2.88 billion in 2019, and is projected to reach $13.80 billion by 2027,...
Psilocybin Data Study Agreement Reached Between Ehave Inc. and Silo Wellness Using Brain Scientific Mapping Neurocap
March 23, 2021 07:00 ET
|
Ehave
MIAMI, March 23, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors, and Silo Wellness Inc. (CSE: SILO) (“Silo...
Digital Therapeutics Market Size to Hit $13.80 Billion, At 20.5% CAGR, Says Allied Market Research
March 15, 2021 10:25 ET
|
Allied Market Research
Portland, OR, March 15, 2021 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report, titled, “Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease...
Ehave CEO Benjamin Kaplan to be Featured on Psychedelic Spotlight Segment of New to the Street Airing on NewsMax on Sunday March 14th at 10:00 AM EST and Fox Business March 15th at 7:30 PM EST
March 12, 2021 12:01 ET
|
Ehave
MIAMI, March 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today CEO and...
Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares to the OTCQB
March 03, 2021 08:30 ET
|
Ehave
MIAMI, March 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...
CCHP Partners with Kiio to Support Medicaid and Marketplace Members During COVID-19 with an Evidence-Based Pain Management Solution
March 02, 2021 12:35 ET
|
Kiio
Madison, March 02, 2021 (GLOBE NEWSWIRE) -- To do more to serve its Medicaid and Marketplace health plan members during COVID, Children’s Community Health Plan (CCHP) partnered with Kiio to expand...
Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression
February 01, 2021 08:30 ET
|
Ehave
MIAMI, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, is announcing plans to roll...